0001104659-21-028268.txt : 20210330 0001104659-21-028268.hdr.sgml : 20210330 20210225163014 ACCESSION NUMBER: 0001104659-21-028268 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOANALYTICAL SYSTEMS INC CENTRAL INDEX KEY: 0000720154 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 351345024 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2701 KENT AVE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 BUSINESS PHONE: 3174634527 MAIL ADDRESS: STREET 1: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 FORMER COMPANY: FORMER CONFORMED NAME: BIOANALYTICAL SYSTEMS INC DATE OF NAME CHANGE: 19970918 CORRESP 1 filename1.htm

bioanalytical systems, iNC.

2701 Kent Avenue

West Lafayette, IN 47906

February 25, 2021

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Nicholas Lamparski

RE:

Bioanalytical Systems, Inc.

Registration Statement on Form S-3

Filed February 19, 2021

File No. 333-253309

Request for Acceleration

Ladies and Gentlemen:

With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Bioanalytical Systems, Inc. (the “Company”), that the Securities and Exchange Commission accelerate the effective date of the Registration Statement to March 1, 2021, at 5:00 p.m. Eastern Time, or as soon as practicable thereafter.

The cooperation of the staff in meeting the timetable described above is very much appreciated.

Please call Stephen J. Hackman of Ice Miller LLP, counsel to the Company, at (317) 236-2289, with any comments or questions regarding the Registration Statement.

	Very truly yours,

	bioanalytical systems, Inc.


	/s/ Robert Leasure, Jr.
	Robert Leasure, Jr.
	President & Chief Executive Officer

cc: Stephen J. Hackman, Esq., Ice Miller LLP